Sign in with Google
|
USD 21.82
Price
0.35
(1.63%)
Day Change
|
|
|---|
ADMA, the overall quality is not quite good (Quality = 54) but the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/E ratio is relatively high
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
In details, quality factors are not good , financial health is not quite good , and ability to make profit is not quite good , ...
| Quality Factors |
|
47% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| Social Score | 14 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 21.82 |
| PBV / Sector |
21.89 / 1.88
|
| Earning Per Share | 0.27 |
| PE / Sector |
78.44 / 17.47
|
| PEG or PE/Growth / Sector |
0.00 / 5.47
|
| Average 1M Daily Value |
78.72 M
|
| Average 1W Daily Value |
51.06 M
|
| Timing Factors |
|
85% |
| Financial Health |
|
50% |
| Ability to Make Profit |
|
58% |
| Return to Investors |
|
41% |
| Registration Details |
| Analyze Date | 2024-11-26 14:33:49 |
| Symbol | ADMA |
| Name | ADMA BIOLOGICS INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 236.39 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 5,006.74 / 3,577.75 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
EXEL 
RPRX 
KRYS 
